Zevra Therapeutics (ZVRA)'s 30-day implied volatility (IV30) was 40.2% at the close on November 10, 2026, down from 45.9% the day before, against a 52-week range of 31.9% to 90.6%. Its 20-day historical volatility was 62.3%.
Data as of November 10, 2026.